Related Experiment Video
Updated: May 1, 2026

Tear-Derived Exosomal miR-15a as New Diagnostic Tool for Diabetic Retinopathy
Published on: December 30, 2025
Serum myeloid-related protein 8/14 complex is associated with microalbuminuria in patients with type 2 diabetes
Christoph Schmaderer1, Stephan Kemmner2, Klaus Burkhardt3
1Department of Nephrology, Klinikum rechts der Isar, Technical University Munich, Ismaninger Str. 22, 81675 Munich, Germany christoph.schmaderer@lrz.tum.de.
Objectives:
Microalbuminuria (MA) is associated independently with cardiovascular risk and progression of renal disease in patients with diabetes and the normal population. MA is an accepted factor for microvascular defects, in particular in patients with diabetes, and is associated with inflammation. Activated transmigrating macrophages are key cells in these inflammatory processes. Based on the theory that myeloid-related protein 8/14 complex (MRP8/14) is secreted by transmigrating macrophages, we hypothesized that MA was accompanied by elevated MRP8/14 and investigated whether MA predicts MRP8/14 in patients with type 2 diabetes.
Methods:
A total of 86 men with type 2 diabetes were grouped according to urinary albumin excretion in normoalbuminuria and MA. Serum MRP8/14 levels were measured by enzyme-linked immunosorbent assay. Established cardiovascular risk factors were quantified in both groups and compared with urinary albumin excretion.
Results:
Albuminuria (mg/day) was positively associated with MRP8/14 (r = 0.34) and systemic blood pressure (r = 0.33). Patients with type 2 diabetes and MA demonstrated significantly higher MRP8/14 levels than patients with normoalbuminuria [median (interquartile range), 1.24 (0.97-2.28) µg/ml versus 0.97 (0.67-1.35) µg/ml, p < 0.05]. Serum creatinine levels, systolic blood pressure (SBP), very low density lipoprotein levels and the incidence of hypertension and coronary artery disease were significantly higher in the group with MA. Both groups did not differ significantly in other cardiovascular risk factors. MA was an independent predictor of serum MRP8/14 levels (β = 0.454) as well as SBP (β = 0.625) and haemoglobin A1c (β = 0.322).
Conclusion:
Our data demonstrate that albumin excretion is associated with the process of macrophage activation determined by MRP8/14 levels. These data not only suggest tissue inflammation as a factor for elevated cardiovascular risk in patients with type 2 diabetes, they further point to a role of macrophage activation in this process.
Insights
Microalbuminuria (MA) in type 2 diabetes patients is linked to higher levels of myeloid-related protein 8/14 (MRP8/14), indicating macrophage activation. This suggests inflammation plays a role in the increased cardiovascular risk associated with MA.
Area of Science:
- Endocrinology
- Nephrology
- Cardiology
Background:
- Microalbuminuria (MA) is an independent predictor of cardiovascular risk and renal disease progression in diabetic patients.
- MA is linked to microvascular defects and inflammation, with activated macrophages playing a key role.
- Myeloid-related protein 8/14 complex (MRP8/14) is secreted by transmigrating macrophages.
Purpose of the Study:
- To investigate the association between microalbuminuria (MA) and elevated myeloid-related protein 8/14 (MRP8/14) levels in patients with type 2 diabetes.
- To determine if MA predicts MRP8/14 levels, suggesting macrophage activation in diabetic cardiovascular risk.
Main Methods:
- 86 men with type 2 diabetes were categorized into normoalbuminuria and MA groups.
- Serum MRP8/14 levels were quantified using enzyme-linked immunosorbent assay.
- Cardiovascular risk factors were assessed and compared between groups.
Main Results:
- Albuminuria showed a positive correlation with MRP8/14 levels (r = 0.34) and systolic blood pressure (r = 0.33).
- Patients with MA had significantly higher MRP8/14 levels compared to those with normoalbuminuria.
- MA independently predicted higher MRP8/14 levels, systolic blood pressure, and hemoglobin A1c.
Conclusions:
- Albumin excretion is associated with macrophage activation, as indicated by MRP8/14 levels.
- These findings suggest tissue inflammation and macrophage activation contribute to elevated cardiovascular risk in type 2 diabetes.
Related Concept Videos
Diabetic Nephropathy
Diabetic Retinopathy
Type I Diabetes III: Clinical Manifestations
Type I Diabetes II: Pathophysiology
Diabetes Mellitus: Type 2 and Gestational
Type II Diabetes Mellitus III: Clinical Manifestations and Diagnosis

